International Society of Glomerular Disease

Exciting news! 🌟 The ISGD Centers of Excellence in Glomerular Disease criteria have been finalized after 2+ years of meticulous work. Learn about our commitment to advance GD care, research, and advocacy! 👉 eu1.hubs.ly/H0k_2sQ0 #ISGD #GlomerularDisease #COEGD

Day 1 of the #SEISMIC C3G and IC-MPGN Summit in Reykjavík is underway! 💚 We’re excited to join @ISGDtweets & CompCure to unite experts, researchers, and advocates tackling clinical challenges and shaping next steps. Stay tuned for more!

Do not miss @ERAkidney G&K and YNP e-seminar! Emphasizing the significance of deep-phenotyping for #genetic diagnostic accuracy and #personalized treatment strategies @torra_roser @HDiniz_ @johnasayer @rupeshrainamd @drjosflynn @sidsdoc Registration: era-online.org/video-pages/cl…

A Clinico-Pathologic Approach to Glomerular Diseases: schematic by @LauraMarianiMD @ASNKidney @GlomCon #BRCU2025 nephsim.com/image-gallery/… #Nephrology #FOAMed

ISGD was at #NephCureHillDay2025 yesterday advocating for the New Era Act, maintaing current NIH funding and preserving the NIDDK. The act aims to advance #GlomerularDisease research and treatments. Learn more: eu1.hubs.ly/H0l_XLh0

See you there! 🌸🌸🌸

Membranous nephropathy has undergone a paradigm shift due to the discovery of unique MN antigens. MN has gone from idiopathic to ➡️ primary vs. secondary ➡️ where an antigen can be detected in ~80% of MN. This is a comprehensive review of each antigen. nature.com/articles/s4158…

Day 2 of SEISMIC ✅ Participants agreed on strategies for quicker and more precise diagnoses, aiming for disease-modifying therapies as the primary treatment. Stay tuned for our summary paper and workgroup developments. As Dr. Carla Nester said, “Get ready for SEISMIC change.” 🌋

Day 1️⃣ of the SEISMIC C3G and IC-MPGN focused on improving the future for those affected by C3G and IC-MPGN. Highlights include the urgency to accelerate diagnosis and treatment, alongside the significance of biomarkers and centers of excellence. Today's insights were powerful💥.

🌋The SEISMIC meeting has ignited at our kickoff dinner. Tomorrow we will begin discussions on important issues in the shifting C3G and IC-MPGN landscape. #GlomerularDisease #C3G #ICMPGN #SEISMIC

‼️Starting tomorrow - the SEISMIC C3G and IC-MPGN Summit! Stakeholders will explore the clinical landscape, challenges and recommendable steps, accelerating access/drug development 🚀. Learn more: eu1.hubs.ly/H0lPv3z0. #GlomerularDisease #C3G #ICMPGN #NephCure #CompCure #ISGD

🎙️World-renowned complement expert Carla Nester joins @koyaljainMD and @kdjhaveri on GN in Ten to talk C3G and all things complement-mediated kidney disease share.transistor.fm/s/67f1e0de 🔜 More C3G insights on the way after this week's SEISMIC summit is-gd.org/seismic-summit

One week left to register for The Columbia Renal Biopsy Course 2025 (7/16-7/18) - both in-person and virtual attendance options are available web.cvent.com/event/c5d72ad3…

We learned a lot & had fun all the while at the Podocyte Conference in Hamburg last month. Thank you so much to the organizers for putting together a terrific set of scientific sessions and social activities @PodocyteIPC @ISGDtweets @Tobias_B_Huber @SannaCherchiLab #kidneyomics

Check out all the abstracts from last month's #PodocyteConference karger.com/gdz/article/5/… and stay tuned for publication of the full meeting report! @NephroKarger @Tobias_B_Huber @HCKH_Hamburg

So proud of our #GN and #onconeph fellow on his last day with us- Dr Gashu Ayehu. Good luck to him for his future ventures. We welcome our next fellow tomorrow ⁦@HofstraKidney⁩ ⁦@ISGDtweets⁩ ⁦@GlomCon⁩ ⁦@onconephsociety⁩

🫘C3G post-kidney transplant =🚨 60%-90% recurrence😳 🆕#CKJ review dives into risk, prevention & 🔬novel complement inhibitors 📖doi.org/10.1093/ckj/sf… 🆓 👇Must-see algorithm + mechanisms + quick summary! #NephTwitter #C3G #KidneyTransplant #MedEd #CKD #Glomerulonephritis

Check out our work on Membranous Nephropathy antigens using LMD/MS 👇 Interesting results! 🔎 Such a great honor to work with @SethiRenalPath and the @MayoClinicNeph and @mayocliniclabs team! @fervenzafernan1 @MayoClinic

What a sparkling meeting on B cell targeting for immune-mediated kidney diseases in Panama! And good to see so many friends and collaborators. Thank you @goKDIGO @BradRovin !

Membranous nephropathy (MN) antigens from a single center in Portugal. Starting point=negative serum anti-PLA2R titer cases. We detected MN antigens: 3 PLA2R, 2 NELL1, & 1 each EXT1/EXT2, HTRA1, THSD7A. Antigens correlated with underlying disease. 1/2 kireports.org/article/S2468-…

WIN-ICON 2025 is open to all nephrology professionals across genders 🌍 Submit your abstracts – oral or poster – and be part of this vibrant celebration of kidney science! #WINICON2025